Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care

Tytuł:
Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care
Autorzy:
Adriane M. dela Cruz
Robrina Walker
Ronny Pipes
Sidarth Wakhlu
Madhukar H. Trivedi
Temat:
Measurement based care
Buprenorphine
Clinical decision support
Medicine (General)
R5-920
Social pathology. Social and public welfare. Criminology
HV1-9960
Źródło:
Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-11 (2021)
Wydawca:
BMC, 2021.
Rok publikacji:
2021
Kolekcja:
LCC:Medicine (General)
LCC:Social pathology. Social and public welfare. Criminology
Typ dokumentu:
article
Opis pliku:
electronic resource
Język:
English
ISSN:
1940-0640
Relacje:
https://doaj.org/toc/1940-0640
DOI:
10.1186/s13722-021-00222-0
Dostęp URL:
https://doaj.org/article/5b1d0c1e63bc41e697b995afcc82736f  Link otwiera się w nowym oknie
Numer akcesji:
edsdoj.5b1d0c1e63bc41e697b995afcc82736f
Czasopismo naukowe
Abstract Background The treatment capacity for opioid use disorder (OUD) lags far behind the number of patients in need of treatment. Capacity is limited, in part, by the limited number of physicians who offer office based OUD treatment with buprenorphine. Measurement based care (MBC) has been proposed as a means to support primary care physicians in treating OUD. Here, we propose a set of measures and a clinical decision support algorithm to provide MBC for the treatment of OUD. Methods We utilized literature search and expert consensus to identify measures for universal screening and symptom tracking. We used expert consensus to create the clinical decision support algorithm. Results The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) tool was selected as the best published measure for universal screening in primary care. No published measure was identified as appropriate for symptom tracking or medication adherence; therefore, we created the OUD Symptom Checklist from the DSM-5 criteria for OUD and the Patient Adherence Questionnaire for Opioid Use Disorder Treatment (PAQ-OUD) to assess medication adherence. We developed and present a clinical decision support algorithm to provide direct guidance regarding treatment interventions during the first 12 weeks of buprenorphine treatment. Conclusion Creation of these tools is the necessary first step for implementation of MBC for the treatment of OUD with buprenorphine in primary care. Further work is needed to test the feasibility and acceptability of these tools. Trial Registration ClinicalTrials.gov; NCT04059016; 16 August 2019; retrospectively registered; https://clinicaltrials.gov/ct2/show/NCT04059016

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies